Prasugrel 10 MG Oral Tablet — RxCUI 855812
RxNorm drug concept · Semantic clinical drug
RxCUI 855812
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
24 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI855812
Official namePrasugrel 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprasugrel (as prasugrel HCl 10.98 MG) 10 MG Oral Tablet
FDA products mapped21
Package NDCs mapped24
Reported Medicaid activity (SDUD)69,460 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Prasugrel: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- After a heart procedure like a stent placement, your arteries need time to heal. During that time, platelets — tiny blood cells — can clump together and form a clot inside the sten...
- What exactly is prasugrel doing for me — why do I need it?
- Please don't — this is really important. Stopping prasugrel too early, especially in the first weeks after your procedure, can cause your stent to clot suddenly, which can trigger...
- Can I ever stop taking this on my own if I feel fine?
🕸️ Concept Web — How Prasugrel 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Prasugrel 10 MG Oral Tablet
RxCUI 855812 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Prasugrel
613391IN
-
Prasugrel
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Effient
855813BN
-
Effient
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Prasugrel Oral Tablet
855811SCDF -
Prasugrel Oral Product
1165745SCDG -
Prasugrel Pill
1165746SCDG -
Prasugrel Oral Tablet [Effient]
855815SBDF -
Effient Oral Product
1173221SBDG -
Effient Pill
1173222SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Prasugrel Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Prasugrel 10 MG
855810SCDC -
Prasugrel 10 MG Oral Tablet [Effient]
855816SBD -
Prasugrel 10 MG [Effient]
855814SBDC
-
Prasugrel 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Prasugrel 10 MG
SCDC · 855810 -
Prasugrel Oral Tablet
SCDF · 855811 -
Prasugrel Oral Product
SCDG · 1165745 -
Prasugrel Pill
SCDG · 1165746
Brand-Name Concepts
-
Prasugrel 10 MG Oral Tablet [Effient]
SBD · 855816 -
Prasugrel 10 MG [Effient]
SBDC · 855814 -
Prasugrel Oral Tablet [Effient]
SBDF · 855815 -
Effient Oral Product
SBDG · 1173221 -
Effient Pill
SBDG · 1173222 -
Effient
BN · 855813
📦 FDA Products & Package NDCs
21 products · 24 package NDCs
24 package NDCs map to RxCUI 855812 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-5185-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5185-93) | Prasugrel | Mylan Pharmaceuticals Inc. | 2017-08-16 |
| 00378-5186-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5186-93) | Prasugrel | Mylan Pharmaceuticals Inc. | 2017-08-15 |
| 00713-0881-30 | 30 TABLET, COATED in 1 BOTTLE (0713-0881-30) | Effient | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 00713-0882-30 | 30 TABLET, COATED in 1 BOTTLE (0713-0882-30) | Effient | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 16729-0272-10 | 30 TABLET, FILM COATED in 1 BOTTLE (16729-272-10) | Prasugrel | Accord Healthcare Inc. | 2019-01-16 |
| 16729-0273-10 | 30 TABLET, FILM COATED in 1 BOTTLE (16729-273-10) | Prasugrel | Accord Healthcare Inc. | 2019-01-16 |
| 29300-0301-13 | 30 TABLET, FILM COATED in 1 BOTTLE (29300-301-13) | Prasugrel | Unichem Pharmaceuticals (USA), Inc. | 2023-10-16 |
| 29300-0302-13 | 30 TABLET, FILM COATED in 1 BOTTLE (29300-302-13) | Prasugrel | Unichem Pharmaceuticals (USA), Inc. | 2023-10-16 |
| 43817-0239-01 | 30 TABLET, FILM COATED in 1 BOTTLE (43817-239-01) | PRASUGREL | Panacea Biotec Limited | 2017-10-16 |
| 43817-0240-01 | 30 TABLET, FILM COATED in 1 BOTTLE (43817-240-01) | PRASUGREL | Panacea Biotec Limited | 2017-10-16 |
| 51407-0444-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-444-30) | Prasugrel | Golden State Medical Supply, Inc. | 2021-01-20 |
| 51407-0445-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-445-30) | Prasugrel | Golden State Medical Supply, Inc. | 2021-01-20 |
| 60505-4642-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-4642-3) | PRASUGREL | Apotex Corp. | 2017-10-16 |
| 60505-4643-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-4643-3) | PRASUGREL | Apotex Corp. | 2017-10-16 |
| 60505-4856-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-4856-3) | PRASUGREL | Apotex Corp. | 2025-02-15 |
| 60687-0883-21 | 30 BLISTER PACK in 1 CARTON (60687-883-21) / 1 TABLET, FILM... | Prasugrel | American Health Packaging | 2025-03-02 |
| 63629-4829-01 | 30 TABLET, FILM COATED in 1 BOTTLE (63629-4829-1) | Prasugrel | Bryant Ranch Prepack | 2024-11-25 |
| 63629-4829-02 | 90 TABLET, FILM COATED in 1 BOTTLE (63629-4829-2) | Prasugrel | Bryant Ranch Prepack | 2024-11-25 |
| 65162-0001-03 | 30 TABLET, FILM COATED in 1 BOTTLE (65162-001-03) | Prasugrel | Amneal Pharmaceuticals LLC | 2018-06-22 |
| 65162-0002-03 | 30 TABLET, FILM COATED in 1 BOTTLE (65162-002-03) | Prasugrel | Amneal Pharmaceuticals LLC | 2018-06-22 |
| 65862-0829-03 | 3 BLISTER PACK in 1 CARTON (65862-829-03) / 10 TABLET, FILM... | Prasugrel | Aurobindo Pharma Limited | 2017-10-16 |
| 65862-0829-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-829-30) | Prasugrel | Aurobindo Pharma Limited | 2017-10-16 |
| 65862-0830-03 | 3 BLISTER PACK in 1 CARTON (65862-830-03) / 10 TABLET, FILM... | Prasugrel | Aurobindo Pharma Limited | 2017-10-16 |
| 65862-0830-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-830-30) | Prasugrel | Aurobindo Pharma Limited | 2017-10-16 |
Observed labelers:
Aurobindo Pharma Limited (4) ·
Apotex Corp. (3) ·
Accord Healthcare Inc. (2) ·
Amneal Pharmaceuticals LLC (2) ·
Bryant Ranch Prepack (2) ·
Cosette Pharmaceuticals, Inc. (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.